Big Data Analytics: Identification of Novel Cancer Progression Gene Signatures for Precision/ Personalized Medicine
ISEF · 2019 Biomedical and Health Sciences Fourth Award
Overview
Precision and personalized medicine are emerging approaches for cancer therapeutics. By characterizing patients’ risk for adverse developments such as tumor progression, specialized treatment plans can be tailored to individual patients. However, most current biomarkers are lacking in performance level, limiting their clinical application in precision/personalized medicine. To identify better biomarkers suitable for precision medicine, a novel discovery pipeline analyzing gene expression profiling, cancer survival gene screens, and clinical data in a large cohort of cancer patients was used. The rationale behind this methodology is that highly-expressed cancer survival genes are better candidates for biomarkers of disease progression. By using this approach, 22 genes were identified as a progression gene signature (PGS) in lung adenocarcinoma (LUAD) and designated as LUAD-PGS. Further analyses using pair-wise comparison of receiver operating characteristic (ROC) curves and risk score calculations revealed that LUAD-PGS significantly outperformed current biomarkers in accurately predicting patient risk for tumor progression. Implementing the same working pipeline, novel PGSs were identified in other cancers with higher performance levels than existing biomarkers. Taken together, the results from this study demonstrate the utility of the new biomarker discovery pipeline developed herein in identifying novel PGSs that more accurately predict patient risk of cancer progression, thereby meeting a need in precision medicine.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2020
A Novel Multi-omic Approach to Identifying Cancer Recurrence-Associated Gene Signatures
ISEF · 2026
Toward Precision Oncology: Integrating Clinical and Mutational Data to Predict Pancreatic Cancer Survival Using Machine Learning
AJAS · 2022
Finding and Analyzing New Target Genes for Treatment of Lung Adenocarcinoma using Bioinformatics
ISEF · 2017
A Multi-Omics Predictive Pipeline for the Discovery of Cancer Driver Genes
CSEF · 2026
Copiloting Predictability with AI and ML to Beat the Second Hit in Colorectal, Breast and Lung Cancers
CSEF · 2015
Enabling Precision Medicine with Big Data: A Cross-Platform Framework to Characterize Gene Presence and Function
ISEF · 2015
Enabling Precision Medicine with Big Data: A Cross-Platform Framework to Computationally Characterize Gene Presence and Function
ISEF · 2024
Enabling Scalable Precision Medicine With STAD: A Novel Computational Platform for Early Recurrence-Free Survival Prediction and Biomarker Discovery in Digital Pathology for Gastrointestinal Cancer Patients
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair